Page last updated: 2024-08-16

resveratrol and glucagon

resveratrol has been researched along with glucagon in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blaak, EE; Holst, JJ; Knop, FK; Konings, E; Schrauwen, P; Timmers, S	1
Carlson, OD; de Cabo, R; Doyle, ME; Egan, JM; Farhang, K; Fiori, JL; Gadkaree, SK; González-Mariscal, I; Kim, W; Krzysik-Walker, SM; Mattison, JA; Moaddel, R; Pearson, KJ; Sanghvi, M; Shin, YK	1
Baur, JA; Becker, LB; Guan, Y; Reilly, PM; Sims, CA; Wang, H; Widlund, AL	1
Deniziak, M; Gwóźdź, K; Roś, P; Szkudelska, K; Szkudelski, T	1
Blomberg, LA; Caperna, TJ; Ramsay, TG; Stoll, MJ	1

Trials

1 trial(s) available for resveratrol and glucagon

Article	Year
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Diabetic medicine : a journal of the British Diabetic Association, 2013, Volume: 30, Issue:10 Topics: Antioxidants; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Postprandial Period; Resveratrol; Stilbenes; Time Factors; Treatment Outcome	2013

Article

Year

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.

Diabetic medicine : a journal of the British Diabetic Association, 2013, Volume: 30, Issue:10

Topics: Antioxidants; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Postprandial Period; Resveratrol; Stilbenes; Time Factors; Treatment Outcome

2013

Other Studies

4 other study(ies) available for resveratrol and glucagon

Article	Year
Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet. Diabetes, 2013, Volume: 62, Issue:10 Topics: Animals; Blood Glucose; Body Weight; Cell Dedifferentiation; Densitometry; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Fluorescent Antibody Technique; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Glycated Hemoglobin; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Macaca mulatta; Nuclear Proteins; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors	2013
Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock. The journal of trauma and acute care surgery, 2014, Volume: 77, Issue:6 Topics: Animals; Blood Glucose; Corticosterone; Glucagon; Glucagon-Like Peptide 1; Hypoglycemia; Insulin; Insulin Resistance; Kidney; Male; Mitochondria; Mitochondria, Liver; Rats, Long-Evans; Reactive Oxygen Species; Resuscitation; Resveratrol; Shock, Hemorrhagic; Stilbenes	2014
Resveratrol alleviates ethanol-induced hormonal and metabolic disturbances in the rat. Physiological research, 2017, 03-31, Volume: 66, Issue:1 Topics: Adiponectin; Animals; Ethanol; Fatty Acids, Nonesterified; Glucagon; Insulin; Lipid Metabolism; Liver; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes; Triglycerides	2017
Regulation of fetuin A gene expression in the neonatal pig liver. Animal : an international journal of animal bioscience, 2018, Volume: 12, Issue:2 Topics: alpha-2-HS-Glycoprotein; Animals; Antioxidants; Birth Weight; Cytokines; Female; Gene Expression Regulation; Glucagon; Growth Hormone; Hepatocytes; Liver; Male; Resveratrol; RNA, Messenger; Stilbenes; Swine	2018